Trial Profile

A phase I trial of vaccination with lethally irradiated lymphoma cells admixed with granulocyte-macrophage colony stimulating factor secreting K562 cells for the treatment of previously untreated or relapsed follicular lymphoma.

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

24 Nov 2020 Biomarkers information updated
17 Sep 2012 Planned end date changed from 1 Oct 2021 to 1 Oct 2024 as reported by ClinicalTrials.gov.
17 Sep 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com